GLP1R and Cirrhosis: Metformin, thiazolidinediones, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors may be useful for patients with NAFLD or NASH, but only thiazolidinediones may be able to attenuate fibrosis or even cirrhosis (Table 2).